Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
The U.S. Food and Drug Administration is talking when they should be listening
KevinMD December 6, 2024
On May 9-10, 2017, the U.S. Food and Drug Administration (FDA) held a workshop titled “Training health care providers on pain management and safe use of opioid analgesics — exploring the path forward.” I attended the workshop in person to offer comments on behalf of chronic pain patients. A summary of my observations at the time was published by the now-defunct Pain News Network. The following extended extract is from workshop proceedings published on May 9, 2017, by the FDA.
To begin this short presentation, I would draw the attention of the members in front [of the workshop] to the fact that, at present, millions of people either hypermetabolize or poorly metabolize opioid medications. This is due to variations...
Today's Sponsors
Today's Sponsor